![Perry Genova](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Perry Genova
Technik-/Wissenschafts-/F&E-Leiter bei
OMNICELL, INC.
Profil
Perry A. Genova is Chief Technology Officer & Senior Vice President at Omnicell, Inc. since 2025.
Former roles include President, Chief Executive Officer & Director at Oncoscope, Inc.; Vice President-Biomedical Engineering at KOS Pharmaceuticals, Inc. from 1996 to 2006; Senior Vice President-Research & Development at Titan Medical, Inc. from 2017 to 2022; Global Vice President at GlaxoSmithKline Sante Grand Public SAS; Vice President at GSK Plc; and Senior Vice President-Research & Development at EndoQuest Robotics, Inc. from 2022 to 2025.
Education includes undergraduate, graduate, and doctorate degrees from The University of North Carolina at Charlotte.
Aktive Positionen von Perry Genova
| Unternehmen | Position | Beginn |
|---|---|---|
| OMNICELL, INC. | Technik-/Wissenschafts-/F&E-Leiter | 31.03.2025 |
Ehemalige bekannte Positionen von Perry Genova
| Unternehmen | Position | Ende |
|---|---|---|
ENDOQUEST ROBOTICS, INC.
 ENDOQUEST ROBOTICS, INC. Medical SpecialtiesHealth Technology Operates as a medical equipment manufacturing company that manufactures endoluminal robotic surgical system | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2025 |
| CONAVI MEDICAL CORP. | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2022 |
KOS Pharmaceuticals, Inc.
 KOS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Corporate Officer/Principal | - |
| GSK PLC | Corporate Officer/Principal | - |
GlaxoSmithKline Sante Grand Public SAS
 GlaxoSmithKline Sante Grand Public SAS Medical DistributorsDistribution Services Wholesales pharmaceutical products | Corporate Officer/Principal | - |
Ausbildung von Perry Genova
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
65
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
KOS Pharmaceuticals, Inc.
KOS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Omnicell, Inc.
 Omnicell, Inc. Information Technology ServicesTechnology Services Provides automated solutions for hospital medication and supply management | Technology Services |
Oncoscope, Inc.
 Oncoscope, Inc. Medical/Nursing ServicesHealth Services Develops optical imaging systems for the early detection of cancers | Health Services |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Titan Medical, Inc.
 Titan Medical, Inc. Medical SpecialtiesHealth Technology Designs and develops robotic surgical technologies | Health Technology |
GlaxoSmithKline Sante Grand Public SAS
GlaxoSmithKline Sante Grand Public SAS Medical DistributorsDistribution Services Wholesales pharmaceutical products | Distribution Services |
The University of North Carolina at Charlotte
 The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ENDOQUEST ROBOTICS, INC.
ENDOQUEST ROBOTICS, INC. Medical SpecialtiesHealth Technology Operates as a medical equipment manufacturing company that manufactures endoluminal robotic surgical system | Health Technology |
